Emergency Use Authorization (EUA) Guidebooks and Other CmAb Resources
Welcome! NICA has collaborated with various pharmaceutical manufacturers to develop in-depth guidance about the COVID-19 antibody therapies currently available under Emergency Use Authorization. Links to additional resources on external sites can also be found here.
NICA collaborated with Regeneron to develop this playbook with in-depth information about Casirivimab + Imdevimab.
Click on the heading or graphic to view the fact sheet for healthcare providers.
Click on the heading or graphic to view the fact sheet for patients, parents, and caregivers in English.
The CDC has developed the COVID-19 Communication Toolkit: For Migrants, Refugees, and Other Limited-English-Proficient Populations in various languages. Resources are available in Spanish, Simplified Chinese, Korean, Tagalog, Hmoob (Hmong), Af Soomaali (Somali), and Vietnamese.